Characterization of striatal lesions produced by glutamate uptake alteration: Cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression

GLIA

Volumn 29, Issue 3, 2000, Pages 222-232

  Lievens, J C ^a   Bernal, F ^b   Forni, C ^a   Mahy, N ^b   Goff, L Kerkerian Le ^a  

^a CNRS   (France)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Astrocytes; Calcium deposits; Excitatory amino acid; Microglia; PDC; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); CALCIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUTAMIC ACID; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MESSENGER RNA; PROTEIN; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; CELL DEATH; CORPUS STRIATUM; FEMALE; GENETICS; GLIOSIS; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; CALCIUM; CELL DEATH; CORPUS STRIATUM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GLUCOSE TRANSPORTER TYPE 1; GLUTAMIC ACID; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOAMINE OXIDASE; MONOSACCHARIDE TRANSPORT PROTEINS; NERVE DEGENERATION; PROTEINS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RNA, MESSENGER;

EID: 0034141567     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0     Document Type: Article

References (59)

1. Arzberger T, Krampfl K, Leimgruber S, Weindl A. 1997. Changes of NMDA receptors subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease: an in situ hybridization study. J Neuropathol Exp Neurol 56:440-454.
2. Beal MF. 1992. Mechanisms of excitotoxicity in neurologic diseases. FASEB J 6:3338-3344.
3. Bignami A, Eng LF, Dahl D, Uyeda CT. 1972. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res 43:429-435.
4. Bouras C, Giannakopoulos P, Good PF, Hsu A, Hof PR, Perl DP. 1996. A laser microprobe mass analysis of trace elements in brain mineralizations and capillaries in Fahr's disease. Acta Neuropathol 92:351-357.
5. Bridges RJ, Hatalski CG, Shim SN, Cummings BJ, Vijayan V, Kundi A, Cotman CW. 1992. Gliotoxic actions of excitatory amino acids. Neuropharmacology 31:899-907.
6. Bridges RJ, Stanley MS, Anderson MW, Cotman CW, Chamberlin AR. 1991. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 34:717-725.
7. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
8. Choi DW. 1992. Excitotoxic cell death. J Neurobiol 23:1261-1276.
9. 2-adrenoceptor binding in the hippocampus after transient global forebrain ischemia in the rat. Neuroscience 82:805-817.
10. Danbolt NC. 1994. The high affinity uptake system for excitatory amino acids in the brain. Prog Neurobiol 44:377-396.
11. Davis EJ, Foster TD, Thomas WE. 1993. Cellular forms and functions of brain microglia. Brain Res Bull 34:73-78.
12. Del Rayo Sanchez-Carbente M, Massieu L. 1999. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J Neurochem 72:129-138.
13. Erecinska M. 1987. The neurotransmitter amino acid transport systems. A fresh outlook on an old problem. Biochem Pharmacol 93:863-867.
14. Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ. 1991. Two genes encode distinct glutamate decarboxylase. Neuron 7:91-100.
15. Fernaud-Espinosa I, Nieto-Sampedro M, Bovolenta P. 1993. Differential activation of microglia and astrocytes in aniso- and isomorphic gliotic tissue. Glia 8:277-291.
16. Gegelashvili G, Schousboe A. 1997. High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol 52:6-15.
17. Gegelashvili G, Schousboe A. 1998. Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull 45:233-238.
18. Gegelashvili G, Danbolt NC, Schousboe A. 1997. Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J Neurochem 69:2612-1615.
19. Haugeto Ø, Ullensvang K, Levy LM, Chaudhry FA, Honoré T, Nielsen M, Lehre KP, Danbolt NC. 1996. Brain glutamate transporter proteins form homomultimers. J Biol Chem 271:27715-27722.
20. Herrmann G, Stünitz H, Nitsch C. 1998. Composition of ibotenic acid-induced calcifications in rat substantia nigra. Brain Res 786: 205-214.
21. Howels RD, Kilpatrick DL, Bhatt R, Monahan JJ, Poonian M, Udenfriend S. 1984. Molecular cloning and sequence determination of rat preproenkephalin cDNA: sensitive probe for studying transcriptional changes in rat tissues. Proc Natl Acad Sci USA 81:7651-7655.
22. Hughes PE, Alexi T, Yoshida T, Schreiber SS, Knusel B. 1996. Excitotoxic lesion of the rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and GADD-45 in the brain areas showing DNA fragmentation. Neuroscience 74:1143-1160.
23. Itzhak Y, Roig-Cantisano A, Norenberg MD. 1995. Ontogeny of peripheral-type benzodiazepine receptors in cultured astrocytes and brain from rat. Brain Res Dev Brain Res 84:62-66.
24. Jin KL, Chen J, Kawaguchi K, Zhu RL, Stetler RA, Simon RP, Graham SH. 1996. Focal ischemia induces expression of the DNA damage-inducible gene GADD45 in the rat brain. NeuroReport 7:1797-1802.
25. Kondo K, Hashimoto H, Kitanaka J-I, Sawada M, Suzumura A, Marrunouchi T, Baba A. 1995. Expression of glutamate transporters in cultured glial cells. Neurosci Lett 188:140-142.
26. Korf J, Postema F. 1984. Regional calcium accumulation and cation shifts in rat brain by kainate. J Neurochem 43:1052-1060.
27. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD. 1987. Three rat preprotachykinin mRNAs encode the neuropeptides Substance P and Neurokinin A. Proc Natl Acad Sci USA 84:881-885.
28. Liévens JC, Dutertre M, Forni C, Salin P, Kerkerian-Le Goff L. 1997. Continuous administration of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion. Mol Brain Res 50:181-189.
29. Mahy N, Prats A, Riveros A, Andrés N, Bernal F. 1999. Basal ganglia calcification induced by excitotoxicity: an experimental model characterized by electron microscopy and X-ray microanalysis. Acta Neuropathol 98:217-225.
30. Mahy N, Bendahan G, Boatell ML, Bjelke B, Tinner B, Olson L, Fuxe K. 1995. Differential brain area vulnerability to long term subcortical excitotoxic lesions. Neuroscience 65:15-25.
31. Mann DMA. 1988. Calcification of the basal ganglia in Down's syndrome and Alzheimer's disease. Acta Neuropathol 76:595-598.
32. Martin LJ, Brambrink AM, Lehmann C, Portera-Cailliau C, Koehler R, Rothstein J, Traystman RJ. 1997. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann Neurol 42:335-348.
33. Massieu L, Tapia R. 1997. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J Neurochem 69:1151-1160.
34. Massieu L, Morales-Villagran A, Tapia R. 1995. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J Neurochem 64:2262-2272.
35. Matute C. 1998. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci USA 95:10229-10234.
36. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. 1998. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4:291-297.
37. McManus JFA, Mowry RW. 1960. Staining methods: histologic and histochemical. New York: Paul B. Hoeber.
38. Meldrum B, Garthwaite J. 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. TIPS 11:379-387.
39. 3H]PK-11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11:314-322.
40. Nagaratnam N, Plew JD. 1998. Extensive intracranial calcification secondary to hypoxia, presenting with dyspraxic gait. Aust Radiol 42:232-233.
41. Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura T. 1990. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 80:319-325.
42. Nitsch C, Schaefer F. 1990. Calcium deposits develop in rat substantia nigra but not striatum several weeks after ibotenic acid injection. Brain Res Rev 25:769-773.
43. Pines G, Danbolt NC, Bjørås, M, Zhang Y, Benhadan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, Kanner BI. 1992. Cloning and expression of a rat brain L-glutamate transporter. Nature 360:464-467.
44. Ridet JL, Malhotra SK, Privat A, Gage FG. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
45. Rogove AD, Tsirka SE. 1998. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 8:19-25.
46. Rothman SM, Olney JW. 1986. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111.
47. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
48. Saura J, Andrés N, Andrade C, Ojuel J, Eriksson K, Mahy N. 1997. Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging 18:497-507.
49. Saura J, Boatell ML, Bendahan G, Mahy N. 1995. Calcium deposits formation and glial reaction in rat brain after ibotenic acid-induced basal forebrain lesions. Eur J Neurosci 7:1569-1578.
50. Schmitt A, Asan E, Püschel B, Jöns T, Kugler P. 1996. Expression of the glutamate transporter GLT1 in neuronal cells of the rat central nervous system: non-radioactive in situ hybridization and comparative immunocytochemistry. Neuroscience 71:989-1004.
51. Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM, Kastan MB, O'Conner PM, Fornace AJ Jr. 1994. Interaction of the p53-regulated protein GADD-45 with proliferating cell nuclear antigen. Science 266:1376-1380.
52. Steinhauser C, Gallo V. 1996. News on glutamate receptors in glial cells. Trends Neurosci 19:339-345.
53. Stephenson DT, Schober DA, Smalstig EB, Mincy RE, Gehlert DR, Clemens JA 1995. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J Neurosci 15:5263-5274.
54. Streit WJ. 1996. The role of microglia in brain injury. Neurotoxicology 17:671-678.
55. Trotti D, Rossi D, Rizzini BL, Bezzi P, Danbolt NC, Racagni G, Volterra A. 1996. Molecular mechanisms of functional alteration of glutamate transporters and relevance to neuropathology. Int Acad Biomed Drug Res 11:41-48.
56. Vermersch P, Leys D, Pruvo JP, Clarisse J, Petit H. 1992. Parkinson's disease and basal ganglia calcifications: prevalence and clinico-radiological correlations. Clin Neurol Neurosurg 94:213-217.
57. Wood PL. 1995. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 17:242-248.
58. Yoshida T, Schneider EL, Mori N. 1994. Cloning of the rat GADD45 cDNA and its mRNA expression in the brain. Gene 151:253-255.
59. Zhu RL, Graham SH, Jin K, Stetler RA, Simon RP, Chen J. 1997. Kainate induces the expression of the DNA damage-inducible gene, GADD45, in the rat brain. Neuroscience 81:707-720.